Diffusion tensor imaging in parkinsonian syndromes: A systematic review and meta-analysis

Neurology

Volumn 80, Issue 9, 2013, Pages 857-864

  Cochrane, Claire J ^a   Ebmeier, Klaus P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DISEASE; CEREBELLAR ATAXIA; COMPARATIVE STUDY; CORTICOBASAL SYNDROME; DEMENTIA; DIFFUSION TENSOR IMAGING; EFFECT SIZE; FRACTIONAL ANISOTROPY; HUMAN; META ANALYSIS; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; SYSTEMATIC REVIEW; BRAIN; DISEASE COURSE; METHODOLOGY; PATHOLOGY; SYNDROME;

BRAIN; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; HUMANS; PARKINSONIAN DISORDERS; SYNDROME;

MLCS; MLOWN;

EID: 84876330064     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318284070c     Document Type: Review

References (56)

1. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003;18:467-486.
2. Volkow ND, Rosen B, Farde L. Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci USA 1997;94:2787-2788.
3. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4:469-480.
4. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis, 1st ed. New York: Academic Press; 1985.
5. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
6. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004;75:481-484.
7. Blain CR, Barker GJ, Jarosz JM, et al. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 2006;67: 2199-2205.
8. Ito M, Watanabe H, Kawai Y, et al. Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry 2007;78: 722-728.
9. Matsui H, Nishinaka K, Oda M, Niikawa H, Kubori T, Udaka F. Dementia in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand 2007;116:177-181.
10. Chan LL, Rumpel H, Yap K, et al. Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1383-1386.
11. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008;29:501-505.
12. Ito S, Makino T, Shirai W, Hattori T. Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy. Neuroradiology 2008;50:981-985.
13. Vaillancourt DE, Spraker MB, Prodoehl J, et al. Highresolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009;72:1378-1384.
14. Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222-1226.
15. Menke RA, Scholz J, Miller KL, et al. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009;47:435-441.
16. Nicoletti G, Manners D, Novellino F, et al. Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 2010;74:988-994.
17. Boelmans K, Bodammer NC, Suchorska B, et al. Diffusion tensor imaging of the corpus callosum differentiates corticobasal syndrome from Parkinson's disease. Parkinsonism Relat Disord 2010;16:498-502.
18. Ibarretxe-Bilbao N, Junque C, Marti MJ, et al. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov Disord 2010;25:1888-1894.
19. Wiltshire K, Concha L, Gee M, Bouchard T, Beaulieu C, Camicioli R. Corpus callosum and cingulum tractography in Parkinson's disease. Can J Neurol Sci 2010;37:595-600.
20. Péran P, Cherubini A, Assogna F, et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010;133:3423-3433.
21. Zhang K, Yu C, Zhang Y, et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. Eur J Radiol 2011;77:269-273.
22. Rolheiser TM, Fulton HG, Good KP, et al. Diffusion tensor imaging and olfactory identification testing in earlystage Parkinson's disease. J Neurol 2011;258:1254-1260.
23. Wang PS, Wu HM, Lin CP, Soong BW. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 2011;53:471-481.
24. Du G, Lewis MM, Styner M, et al. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 2011;26:1627-1632.
25. Focke NK, Helms G, Pantel PM, et al. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. AJNR Am J Neuroradiol 2011;32:2087- 2092.
26. Zhan W, Kang GA, Glass GA, et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2012;27:90-97.
27. Padovani A, Borroni B, Brambati SM, et al. Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2006;77:457-463.
28. Erbetta A, Mandelli ML, Savoiardo M, et al. Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 2009;30: 1482-1487.
29. Knake S, Belke M, Menzler K, et al. In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 2010; 25:1232-1238.
30. Lehéricy S, Hartmann A, Lannuzel A, et al. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Brain 2010;133:2410-2425.
31. Kvickström P, Eriksson B, van Westen D, Lätt J, Elfgren C, Nilsson C. Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractography. BMC Neurol 2011;11:13.
32. Whitwell JL, Master AV, Avula R, et al. Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol 2011;68:753-760.
33. Shiga K, Yamada K, Yoshikawa K, Mizuno T, Nishimura T, Nakagawa M. Local tissue anisotropy decreases in cerebellopetal fibers and pyramidal tract in multiple system atrophy. J Neurol 2005;252:589-596.
34. Lu JJ, Wang H, Feng F, Fu HH, Jin ZY, Cui LY. Quantitative evaluation of the nigrostriatal projection in multiple system atrophy by MR diffusion tensor imaging: a preliminary study. Chin J Med Imaging Technol 2006;22:990-993.
35. Oishi K, Konishi J, Mori S, et al. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy. J Neuroimaging 2009;19:127-131.
36. Tir M, Delmaire C, le Thuc V, et al. Motor-related circuit dysfunction in MSA-P: usefulness of combined wholebrain imaging analysis. Mov Disord 2009;24:863-870.
37. Prakash N, Hageman N, Hua X, Toga AW, Perlman SL, Salamon N. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage 2009;47(suppl 2):T72-T81.
38. Tha KK, Terae S, Yabe I, et al. Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology 2010;255:563-569.
39. Makino T, Ito S, Kuwabara S. Involvement of pontine transverse and longitudinal fibers in multiple system atrophy: a tractography-based study. J Neurol Sci 2011;303:61-66.
40. Borroni B, Garibotto V, Agosti C, et al. White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol 2008;65:796-801.
41. Bozzali M, Falini A, Cercignani M, et al. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain 2005;128:1595-1604.
42. Firbank MJ, Blamire AM, Krishnan MS, et al. Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease. Psychiatry Res 2007;155:135-145.
43. Ota M, Sato N, Ogawa M, et al. Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging. NMR Biomed 2009;22:280-284.
44. Lee JE, Park HJ, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxelbased diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2010;81:320-326.
45. Kantarci K, Avula R, Senjem ML, et al. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 2010;74:1814-1821.
46. Kiuchi K, Morikawa M, Taoka T, et al. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study. J Psychiatr Res 2011;45:1095-1100.
47. Firbank MJ, Blamire AM, Teodorczuk A, Teper E, Mitra D, O'Brien JT. Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. Psychiatry Res 2011;194:176-183.
48. Hattori T, Yuasa T, Aoki S, et al. Altered microstructure in corticospinal tract in idiopathic normal pressure hydrocephalus: comparison with Alzheimer disease and Parkinson disease with dementia. AJNR Am J Neuroradiol 2011; 32:1681-1687.
49. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114: 2283-2301.
50. Boska MD, Hasan KM, Kibuule D, et al. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Neurobiol Dis 2007;26:590-596.
51. Soria G, Aguilar E, Tudela R, Mullol J, Planas AM, Marin C. In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model. Eur J Neurosci 2011;33:1551-1560.
52. Schocke MF, Seppi K, Esterhammer R, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004; 21:1443-1451.
53. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
54. Zhang Y, Schuff N, Jahng GH, et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007;68:13-19.
55. Johansen-Berg H, Behrens TE. Diffusion MRI: From Quantitative Measurement to In Vivo Neuroanatomy, 1st ed. London: Academic Press; 2009.
56. O'Keeffe GC, Michell AW, Barker RA. Biomarkers in Huntington's and Parkinson's disease. Ann NY Acad Sci 2009;1180:97-110.